You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

SPECIALTY GRAND CHALLENGE article

Front. Cell. Neurosci., 23 December 2020

Sec. Non-Neuronal Cells

Volume 14 - 2020 | https://doi.org/10.3389/fncel.2020.628347

A Diversity of Cell Types, Subtypes and Phenotypes in the Central Nervous System: The Importance of Studying Their Complex Relationships

  • 1. Axe Neurosciences, Centre de recherche du CHU de Québec - Université Laval, Québec, QC, Canada

  • 2. Département de Médecine Moléculaire, Université Laval, Québec, QC, Canada

  • 3. Department of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada

  • 4. Division of Medical Sciences, University of Victoria, Victoria, BC, Canada

  • 5. Department of Biochemistry and Molecular Biology, Faculty of Medicine, The University of British Colombia, Vancouver, BC, Canada

Article metrics

View details

16

Citations

3,4k

Views

916

Downloads

All the cell types in the central nervous system (CNS) cooperate to mediate proper development, function, and plasticity. Similarly, brain repair and neuroprotection, but also demyelination, synaptic loss and neurodegeneration, were increasingly shown to involve non-neuronal cells—both glial cells and peripheral immune cells—among the CNS parenchyma. Adding another degree of complexity, the non-neuronal cell populations are emerging as comprised of different subtypes, endowed with unique properties and functions at steady-state, and which can adopt various phenotypes upon exposure to homeostatic challenges. As a consequence, studying the multidirectional relationships between these different cell types, subtypes and phenotypes in the CNS is now required to provide insights into the mechanisms underlying physiological processes such as neuronogenesis, axon guidance, myelination, vascular formation and remodeling, regulation of neuronal activity, as well as synaptic formation, function and plasticity, and behavioral outputs, among other essential CNS functions.

A Diversity of Cell Types, Subtypes, and Phenotypes

In the CNS, the different types of neurons, which are identified by their neurotransmitters, neurotrophic or neuroprotective factors (Que et al., 2019; Sugino et al., 2019; Cizeron et al., 2020), are accompanied by non-neuronal cells showing similar, or greater levels of heterogeneity. This cellular diversity pertains to glial cells (microglia, astrocytes, cells of the oligodendrocytic lineage) and the peripheral immune cells that can infiltrate the CNS (Oberheim et al., 2012; Butt and Verkhratsky, 2018; Foerster et al., 2019; Stratoulias et al., 2019; Dumas and Prinz, 2020). While the microglial field rejected the M1 and M2 categorization (Martinez and Gordon, 2014; Ransohoff, 2016), the A1 and A1 astrocytic dichotomy is increasingly controversial (Oberheim et al., 2012; Verkhratsky and Nedergaard, 2018; Khakh and Deneen, 2019; Westergard and Rothstein, 2020). Cells of the oligodendrocytic lineage are also emerging as a diverse population with different subsets co-existing among the CNS (Foerster et al., 2019). Similarly, peripheral immune cells comprised of granulocytes (neutrophils, eosinophils, and basophils), monocytes, and lymphocytes (T cells and B cells) are highly heterogeneous, and accompanied by additional CNS border-associated populations, yet the nature of the cells infiltrating the CNS, and their distinctive properties once in the CNS environment are less understood (Theret et al., 2019; Dumas and Prinz, 2020). Accumulating findings reveal that glial and peripheral immune cells display distinct subsets that vary in their localization, epigenetic signature, protein and gene expression, but also in their morphological and ultrastructural attributes (Bisht et al., 2016; Ayata et al., 2018; Silvin and Ginhoux, 2018; Foerster et al., 2019; Khakh and Deneen, 2019; Stratoulias et al., 2019; Burns et al., 2020; Castellani and Schwartz, 2020; St-Pierre et al., 2020; Tan et al., 2020; Westergard and Rothstein, 2020). Whether the non-neuronal subsets in the CNS indicate the existence of different subtypes, with unique intrinsic properties and specialized functions, or reflect phenotypes that change their properties and functions upon exposure to challenges, or both, remains in most cases elusive. Understanding how the glial and peripheral immune cell heterogeneity determines varied functions in the CNS, at steady-state and upon various challenges, is importantly required to design cellular interventions that specifically target (modulate, stimulate or inhibit) microglia, astrocytes, oligodendrocytic lineage cells or peripheral immune cells performing contextually-desirable or undesirable functions.

The Challenge of Studying Their Complex Relationships

Distinguishing between glial and immune cell subtypes and phenotypes in the CNS requires fate mapping tools that allow to follow individual cells over time. Such approaches, which are becoming increasingly available, have been used by pioneering investigations to determine the origin of tissue resident macrophages, including microglia (Prinz et al., 2014; Perdiguero and Geissmann, 2016), or the turnover and longevity of microglia within the CNS (Askew et al., 2017; Füger et al., 2017; Tay et al., 2017b), among other important findings. To complement the fate mapping strategies, in situ and in vivo approaches should be prioritized to study the biological relevance of glial and immune diversity in the CNS, considering that in vitro and ex vivo preparations modify non-neuronal cell responses (Hellwig et al., 2013; Gosselin et al., 2014). Recent technological advances such as single cell transcriptome analysis have revealed an unprecedented heterogeneity in the non-neuronal cells of the CNS's molecular signatures (Krasemann et al., 2017; Hammond et al., 2019; Kierdorf et al., 2019; Deczkowska et al., 2020). Nevertheless, whether the glial and immune cells in the CNS are multitasking or perform specialized functions still remains largely undetermined. Considering that essential CNS functions emerge from the dynamic interactions between all cell types in the CNS, including learning and memory, judgement, emotional transformation, decision making, as well as behavioral outputs, it would be essential to unravel the complex relationships between cell types, subtypes, and phenotypes of neuronal and non-neuronal cells in the CNS. The neurons, microglia, astrocytes, and oligodendrocytic lineage cells have been shown to interact with another, structurally and functionally, and they communicate with the peripheral leukocytes infiltrating the CNS or transiting via the perivascular space and other CNS borders (Neuroimmune Communication, 2017; Tay et al., 2017c; Carrier et al., 2020). Microglia can control astrocytic functions, and vice versa, astrocytes can influence microglia, and the same holds for the reciprocal crosstalks taking place between astrocytes, microglia, and oligodendrocytic lineage cells (Béchade et al., 2013; Kettenmann et al., 2013; Domingues et al., 2016; Liddelow et al., 2017; Matejuk and Ransohoff, 2020). Within this integrative viewpoint, collaborative research endeavors that bridge complementary expertise with the different non-neuronal cell types, subtypes and phenotypes, are now required to provide maximal insights into the functional relevance of these multidimensional relationships within the CNS.

The Individual Circumstances Increasing Variability

Non-neuronal cell types, subtypes and phenotypes vary between CNS regions, stages of life, sex, specie, and context of health or disease (Silvin and Ginhoux, 2018; Foerster et al., 2019; Khakh and Deneen, 2019; Stratoulias et al., 2019; Castellani and Schwartz, 2020; Tan et al., 2020; Westergard and Rothstein, 2020). Their diversity is modulated by the genetic vulnerabilities, environmental challenges (e.g., stress, infection, pollution), lifestyle factors (e.g., diet, sleep, physical activity, alcohol, cannabis), peripheral comorbidities (e.g., asthma, colitis, arthritis) and other individual circumstances (e.g., exposure to nature, social support), thus tremendously increasing the variability (Hanamsagar and Bilbo, 2017; Tay et al., 2017a; Savage and Tremblay, 2019; Madore et al., 2020). The non-neuronal cells further display differences in their CNS colonization, maturation, gene and protein expression, morphology, ultrastructure, function, and response to challenges between the sexes (Schwarz and Bilbo, 2012; Hui St.-Pierre et al., 2018; Nelson et al., 2019; Bordeleau et al., 2020; Yasuda et al., 2020). In the periphery, the concept of “immunobiography” has been formulated, to reflect the tremendous inter-individual differences in immune function cumulating during life, and propose the idea that the individual immune signature can inform in a very sensitive manner on the state of health or disease, and allow to predict the outcome of various treatment strategies (Del Giudice et al., 2017; Franceschi et al., 2017). Similarly, the physiological and immune functions of both microglia and astrocytes are regulated by a multitude of external influences, which can induce cellular memory and epigenetic remodeling (Reemst et al., 2016; Valero et al., 2016; Tay et al., 2017a; Ayata et al., 2018; Murphy-Royal et al., 2019; Wheeler et al., 2019; Madore et al., 2020). As a consequence, elucidating how various individual circumstances guide the multidimensional relationships between neuronal and non-neuronal cell types, subtypes and phenotypes in the CNS, is expected to provide unprecedented opportunities to develop personalized treatment strategies for a wide variety of neurodevelopmental, neuropsychiatric and neurodegenerative diseases in which the neuronal and non-neuronal cells of the CNS are together critically involved.

Statements

Author contributions

The author confirms being the sole contributor of this work and has approved it for publication.

Acknowledgments

M-ÈT is a Canada Research Chair Tier II in Neurobiology of Aging and Cognition.

Conflict of interest

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  • 1

    Askew K. Li K. Olmos-Alonso A. Garcia-Moreno F. Liang Y. Richardson P. et al . (2017). Coupled proliferation and apoptosis maintain the rapid turnover of microglia in the adult brain. Cell Rep.18, 391405. 10.1016/j.celrep.2016.12.041

  • 2

    Ayata P. Badimon A. Strasburger H. J. Duff M. K. Montgomery S. E. Loh Y.-H. E. et al . (2018). Epigenetic regulation of brain region-specific microglia clearance activity. Nature Neurosci.21, 10491060. 10.1038/s41593-018-0192-3

  • 3

    Béchade C. Cantaut-Belarif Y. Bessis A. (2013). Microglial control of neuronal activity. Front. Cell. Neurosci.7:32. 10.3389/fncel.2013.00032

  • 4

    Bisht K. Sharma K. P. Lecours C. Sánchez M. G. El Hajj H. Milior G. et al . (2016). Dark microglia: a new phenotype predominantly associated with pathological states. Glia64, 826839. 10.1002/glia.22966

  • 5

    Bordeleau M. Lacabanne C. Fernández de Cossío L. Vernoux N. Savage J. C. González-Ibáñez F. et al . (2020). Microglial and peripheral immune priming is partially sexually dimorphic in adolescent mouse offspring exposed to maternal high-fat diet. J. Neuroinflamm.17:264. 10.1186/s12974-020-01914-1

  • 6

    Burns J. C. Cotleur B. Walther D. M. Bajrami B. Rubino S. J. Wei R. et al . (2020). Differential accumulation of storage bodies with aging defines discrete subsets of microglia in the healthy brain. Elife9:e57495. 10.7554/eLife.57495.sa2

  • 7

    Butt A. Verkhratsky A. (2018). Neuroglia: realising their true potential. Brain Neurosci. Adv.2, 208215. 10.1177/2398212818817495

  • 8

    Carrier M. Robert M.-È. González Ibáñez F. Desjardins M. Tremblay M.-È. (2020). Imaging the neuroimmune dynamics across space and time. Front. Neurosci.14:903. 10.3389/fnins.2020.00903

  • 9

    Castellani G. Schwartz M. (2020). Immunological features of non-neuronal brain cells: implications for Alzheimer's Disease immunotherapy. Trends Immunol.41, 794804. 10.1016/j.it.2020.07.005

  • 10

    Cizeron M. Qiu Z. Koniaris B. Gokhale R. Komiyama N. H. Fransén E. et al . (2020). A brain-wide atlas of synapses across the mouse lifespan. Science369, 270275. 10.1126/science.aba3163

  • 11

    Deczkowska A. Weiner A. Amit I. (2020). The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway. Cell181, 12071217. 10.1016/j.cell.2020.05.003

  • 12

    Del Giudice G. Goronzy J. J. Grubeck-Loebenstein B. Lambert P.-H. Mrkvan T. Stoddard J. J. et al . (2017). Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging. npj Aging Mech. Dis.4, 18. 10.1038/s41514-017-0020-0

  • 13

    Domingues H. S. Portugal C. C. Socodato R. Relvas J. B. (2016). Oligodendrocyte, astrocyte, and microglia crosstalk in myelin development, damage, and repair. Front. Cell Dev. Biol.4:79. 10.3389/fcell.2016.00079

  • 14

    Dumas A. A. Prinz M. (2020). The myeloid side of the CNS. Brain Pathol.e12907. 10.1111/bpa.12907. [Epub ahead of print].

  • 15

    Foerster S. Hill M. F. E. Franklin R. J. M. (2019). Diversity in the oligodendrocyte lineage: plasticity or heterogeneity?Glia67, 17971805. 10.1002/glia.23607

  • 16

    Franceschi C. Salvioli S. Garagnani P. de Eguileor M. Monti D. Capri M. (2017). Immunobiography and the heterogeneity of immune responses in the elderly: a focus on inflammaging and trained immunity. Front. Immunol.8:982. 10.3389/fimmu.2017.00982

  • 17

    Füger P. Hefendehl J. K. Veeraraghavalu K. Wendeln A.-C. Schlosser C. Obermüller U. et al . (2017). Microglia turnover with aging and in an Alzheimer's model via long-term in vivo single-cell imaging. Nat. Neurosci.20, 13711376. 10.1038/nn.4631

  • 18

    Gosselin D. Link V. M. Romanoski C. E. Fonseca G. J. Eichenfield D. Z. Spann N. J. et al . (2014). Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell159, 13271340. 10.1016/j.cell.2014.11.023

  • 19

    Hammond T. R. Dufort C. Dissing-Olesen L. Giera S. Young A. Wysoker A. et al . (2019). Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes. Immunity50, 253271.e6. 10.1016/j.immuni.2018.11.004

  • 20

    Hanamsagar R. Bilbo S. D. (2017). Environment matters: microglia function and dysfunction in a changing world. Curr. Opin. Neurobiol.47, 146155. 10.1016/j.conb.2017.10.007

  • 21

    Hellwig S. Heinrich A. Biber K. (2013). The brain's best friend: microglial neurotoxicity revisited. Front. Cell. Neurosci.7:71. 10.3389/fncel.2013.00071

  • 22

    Hui St.-Pierre A. El Hajj H. Remy Y. Hébert S. S. Luheshi G. N. et al . (2018). Prenatal immune challenge in mice leads to partly sex-dependent behavioral, microglial, and molecular abnormalities associated with schizophrenia. Front. Mol. Neurosci.11:13. 10.3389/fnmol.2018.00013

  • 23

    Kettenmann H. Kirchhoff F. Verkhratsky A. (2013). Microglia: new roles for the synaptic stripper. Neuron77, 1018. 10.1016/j.neuron.2012.12.023

  • 24

    Khakh B. S. Deneen B. (2019). The emerging nature of astrocyte diversity. Ann. Rev. Neurosci.42, 187207. 10.1146/annurev-neuro-070918-050443

  • 25

    Kierdorf K. Masuda T. Jordão M. J. C. Prinz M. (2019). Macrophages at CNS interfaces: ontogeny and function in health and disease. Nat. Rev. Neurosci.20, 547562. 10.1038/s41583-019-0201-x

  • 26

    Krasemann S. Madore C. Cialic R. Baufeld C. Calcagno N. El Fatimy R. et al . (2017). The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity47, 566581.e9. 10.1016/j.immuni.2017.08.008

  • 27

    Liddelow S. A. Guttenplan K. A. Clarke L. E. Bennett F. C. Bohlen C. J. Schirmer L. et al . (2017). Neurotoxic reactive astrocytes are induced by activated microglia. Nature541, 481487. 10.1038/nature21029

  • 28

    Madore C. Yin Z. Leibowitz J. Butovsky O. (2020). Microglia, lifestyle stress, and neurodegeneration. Immunity52, 222240. 10.1016/j.immuni.2019.12.003

  • 29

    Martinez F. O. Gordon S. (2014). The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep6:13. 10.12703/P6-13

  • 30

    Matejuk A. Ransohoff R. M. (2020). Crosstalk between astrocytes and microglia: an overview. Front. Immunol.11:1416. 10.3389/fimmu.2020.01416

  • 31

    Murphy-Royal C. Gordon G. R. Bains J. S. (2019). Stress-induced structural and functional modifications of astrocytes-Further implicating glia in the central response to stress. Glia67, 18061820. 10.1002/glia.23610

  • 32

    Nelson L. H. Saulsbery A. I. Lenz K. M. (2019). Small cells with big implications: microglia and sex differences in brain development, plasticity and behavioral health. Prog. Neurobiol.176, 103119. 10.1016/j.pneurobio.2018.09.002

  • 33

    Neuroimmune Communication (2017). Nat. Immunol.18:115. 10.1038/ni.3676

  • 34

    Oberheim N. A. Goldman S. A. Nedergaard M. (2012). Heterogeneity of astrocytic form and function. Methods Mol. Biol.814, 2345. 10.1007/978-1-61779-452-0_3

  • 35

    Perdiguero E. G. Geissmann F. (2016). The development and maintenance of resident macrophages. Nat. Immunol.17, 28. 10.1038/ni.3341

  • 36

    Prinz M. Tay T. L. Wolf Y. Jung S. (2014). Microglia: unique and common features with other tissue macrophages. Acta Neuropathol.128, 319331. 10.1007/s00401-014-1267-1

  • 37

    Que L. Winterer J. Földy C. (2019). Deep survey of GABAergic interneurons: emerging insights from gene-isoform transcriptomics. Front. Mol. Neurosci.12:115. 10.3389/fnmol.2019.00115

  • 38

    Ransohoff R. M. (2016). A polarizing question: do M1 and M2 microglia exist?Nat. Neurosci.19, 987991. 10.1038/nn.4338

  • 39

    Reemst K. Noctor S. C. Lucassen P. J. Hol E. M. (2016). The indispensable roles of microglia and astrocytes during brain development. Front. Hum. Neurosci.10:566. 10.3389/fnhum.2016.00566

  • 40

    Savage J. C. Tremblay M.-È. (2019). Studying laboratory mice - into the wild. Trends Neurosci.42, 566568. 10.1016/j.tins.2019.05.004

  • 41

    Schwarz J. M. Bilbo S. D. (2012). Sex, glia, and development: interactions in health and disease. Horm. Behav.62, 243253. 10.1016/j.yhbeh.2012.02.018

  • 42

    Silvin A. Ginhoux F. (2018). Microglia heterogeneity along a spatio-temporal axis: More questions than answers. Glia66, 20452057. 10.1002/glia.23458

  • 43

    St-Pierre M.-K. Šimončičová E. Bögi E. Tremblay M.-È. (2020). Shedding light on the dark side of the microglia. ASN Neuro12:1759091420925335. 10.1177/1759091420925335

  • 44

    Stratoulias V. Venero J. L. Tremblay M.-È. Joseph B. (2019). Microglial subtypes: diversity within the microglial community. EMBO J.38:e101997. 10.15252/embj.2019101997

  • 45

    Sugino K. Clark E. Schulmann A. Shima Y. Wang L. Hunt D. L. et al . (2019). Mapping the transcriptional diversity of genetically and anatomically defined cell populations in the mouse brain. eLife8:e38619. 10.7554/eLife.38619.048

  • 46

    Tan Y.-L. Yuan Y. Tian L. (2020). Microglial regional heterogeneity and its role in the brain. Mol. Psychiatry25, 351367. 10.1038/s41380-019-0609-8

  • 47

    Tay T. L. Béchade C. D'Andrea I. St-Pierre M.-K. Henry M. S. Roumier A. et al . (2017a). Microglia gone rogue: impacts on psychiatric disorders across the lifespan. Front. Mol. Neurosci.10:421. 10.3389/fnmol.2017.00421

  • 48

    Tay T. L. Mai D. Dautzenberg J. Fernández-Klett F. Lin G. Sagar null et al . (2017b). A new fate mapping system reveals context-dependent random or clonal expansion of microglia. Nat. Neurosci.20, 793803. 10.1038/nn.4547

  • 49

    Tay T. L. Savage J. C. Hui C. W. Bisht K. Tremblay M.-È. (2017c). Microglia across the lifespan: from origin to function in brain development, plasticity and cognition. J. Physiol.595, 19291945. 10.1113/JP272134

  • 50

    Theret M. Mounier R. Rossi F. (2019). The origins and non-canonical functions of macrophages in development and regeneration. Development146:dev156000. 10.1242/dev.156000

  • 51

    Valero J. Paris I. Sierra A. (2016). Lifestyle shapes the dialogue between environment, microglia, and adult neurogenesis. ACS Chem. Neurosci.7, 442453. 10.1021/acschemneuro.6b00009

  • 52

    Verkhratsky A. Nedergaard M. (2018). Physiology of Astroglia. Physiol. Rev.98, 239389. 10.1152/physrev.00042.2016

  • 53

    Westergard T. Rothstein J. D. (2020). Astrocyte diversity: current insights and future directions. Neurochem. Res.45, 12981305. 10.1007/s11064-020-02959-7

  • 54

    Wheeler M. A. Jaronen M. Covacu R. Zandee S. E. J. Scalisi G. Rothhammer V. et al . (2019). Environmental control of astrocyte pathogenic activities in CNS inflammation. Cell176, 581596.e18. 10.1016/j.cell.2018.12.012

  • 55

    Yasuda K. Maki T. Kinoshita H. Kaji S. Toyokawa M. Nishigori R. et al . (2020). Sex-specific differences in transcriptomic profiles and cellular characteristics of oligodendrocyte precursor cells. Stem Cell Res.46:101866. 10.1016/j.scr.2020.101866

Summary

Keywords

microglia, astrocyte, oligodendrocyte lineage cell, peripheral immune cell, subtypes, diversity, interactions, CNS

Citation

Tremblay M-È (2020) A Diversity of Cell Types, Subtypes and Phenotypes in the Central Nervous System: The Importance of Studying Their Complex Relationships. Front. Cell. Neurosci. 14:628347. doi: 10.3389/fncel.2020.628347

Received

11 November 2020

Accepted

13 November 2020

Published

23 December 2020

Volume

14 - 2020

Edited and reviewed by

Christian Hansel, University of Chicago, United States

Updates

Copyright

*Correspondence: Marie-Ève Tremblay

This article was submitted to Non-Neuronal Cells, a section of the journal Frontiers in Cellular Neuroscience

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics